Virus News and Research

Latest Virus News and Research

Study explores differential antibody-mediated effector functions evoked by two mRNA-based COVID-19 vaccines

Researchers evaluated the differential humoral immune response to two COVID-19 vaccines - messenger ribonucleic acid (mRNA)-1273 and BNT162b2.

2 Aug 2022

Pediatric adjuvant formulation offers protection against RSV in newborns

Respiratory syncytial virus (RSV) is the leading global cause of death in children under age 5 and lacks an effective vaccine. In a study from the Precision Vaccines Program at Boston Children's Hospital, a new vaccine formulation protected newborn mice against infection and evoked strong responses in immune cells from human newborns in the laboratory. Results were reported August 2 in Nature Communications.

2 Aug 2022

Study aims to assess the accuracy of influenza rapid diagnostic tests

JMIR Publications recently published "Diagnostic Accuracy of an At-Home, Rapid Self-test for Influenza: Prospective Comparative Accuracy Study" in JMIR Public Health and Surveillance which reported that rapid diagnostic tests (RDTs) for influenza used by individuals at home could potentially expand access to testing and reduce the impact of influenza on health systems.

2 Aug 2022

Dissemination and implementation of Google Apple exposure notification system to mitigate COVID-19 risk

JMIR Publications recently published "Dissemination and Implementation of a Google Apple Exposure Notification System for COVID-19 Risk Mitigation at a National Public University: Protocol for a Pilot Evaluation Study in a Real-World Setting" in JMIR Research Protocols which reported that this paper describes the protocol for South Carolina Safer Together, developed by Clemson University to design, deploy, and evaluate multilevel communication and dissemination and implementation (D&I) strategies in line with recommendations from governmental and educational agencies to mitigate the risk of exposure to COVID-19.

2 Aug 2022

The time has come for DIY mandates on covid

Here we are in the grip of yet another covid-19 surge, yet most people I see out and about are behaving as if the pandemic is over. And I live in Los Angeles County, whose public health department is arguably one of the most vigilant and proactive in the U.S.

2 Aug 2022

Study suggests peimine may be a potent inhibitor of SARS-CoV-2 variant infection

A recent study published in the Journal of Food Biochemistry discovered that peimine from Fritillaria might be a possible SARS-CoV-2 variant infection inhibitor.

2 Aug 2022

mRNA vaccines induce faster antibody response against infectious diseases

A new study describes that mRNA vaccines induce antigen-specific antibody response within a very short period of time after immunization.

2 Aug 2022

The efficacy of honokiol in inhibiting SARS-CoV-2 replication in cell culture

Researchers evaluated the efficacy of honokiol in inhibiting SARS-CoV-2 replication in cell cultures.

2 Aug 2022

The impact of respiratory droplet volume and their evaporation kinetics on environmental stability of respiratory viruses

Researchers measured the impact of initial respiratory droplet volume and relative humidity on the environmental stability of respiratory viruses, including influenza A and SARS-CoV-2.

2 Aug 2022

Reduced severity of COVID-19 in pregnant women during the Omicron wave

A new study assesses the clinical outcomes of COVID-19 in pregnant women to determine whether Omicron and vaccination status impacted disease severity.

1 Aug 2022

Symptoms of monkeypox differ from previous outbreaks

A new study describes the clinical characteristics of monkeypox infections during the current outbreak.

1 Aug 2022

Nasal epithelium of children inhibits infection and replication of ancestral SARS-CoV-2

SARS-CoV-2 causes a broad range of clinical symptoms, including potentially fatal acute respiratory distress syndrome (ARDS).

1 Aug 2022

Study: SARS-CoV-2 variants of concern and biological sex of patients affect molnupiravir efficacy

SARS-CoV-2 variants of concern and the biological sex of patients affect the efficacy of molnupiravir, the first orally available drug approved for outpatient use against COVID-19, according to a new study led by researchers in the Center for Translational Antiviral Research in the Institute for Biomedical Sciences at Georgia State University.

1 Aug 2022

What is the safety of Molnupiravir against SARS-CoV-2 in the elderly?

A new study assessed the safety of the oral administration of Molnupiravir to elderly patients––aged 80 or older, hospitalized with COVID-19.

1 Aug 2022

NIH updates its strategic plan for hepatitis B research

The National Institutes of Health has updated its Strategic Plan for NIH Research to Cure Hepatitis B, a roadmap for ending the hepatitis B epidemic, focused on developing a cure as well as improved strategies for vaccination, screening and follow-up care.

1 Aug 2022

Virus News and Research

Latest Virus News and Research

Study explores differential antibody-mediated effector functions evoked by two mRNA-based COVID-19 vaccines

Pediatric adjuvant formulation offers protection against RSV in newborns

Study aims to assess the accuracy of influenza rapid diagnostic tests

Dissemination and implementation of Google Apple exposure notification system to mitigate COVID-19 risk

The time has come for DIY mandates on covid

Study suggests peimine may be a potent inhibitor of SARS-CoV-2 variant infection

mRNA vaccines induce faster antibody response against infectious diseases

The efficacy of honokiol in inhibiting SARS-CoV-2 replication in cell culture

The impact of respiratory droplet volume and their evaporation kinetics on environmental stability of respiratory viruses

Reduced severity of COVID-19 in pregnant women during the Omicron wave

Symptoms of monkeypox differ from previous outbreaks

Nasal epithelium of children inhibits infection and replication of ancestral SARS-CoV-2

Study: SARS-CoV-2 variants of concern and biological sex of patients affect molnupiravir efficacy

What is the safety of Molnupiravir against SARS-CoV-2 in the elderly?

NIH updates its strategic plan for hepatitis B research

Textile vest with integrated acoustic sensors records noises in the lungs

Würzburg scientists are working on the development of new drugs to combat monkeypox

Scientists report exceptional selection pressure on coronavirus host receptors in bats compared to other mammals

The recent progress in investigating the inhibitory impact of nanosponges and antiviral delivery against SARS-CoV-2

The first viral metagenomic analysis of the soprano pipistrelle bat of Sweden

A new way of characterising biomolecules eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in